8-K
filed October 16, 2023, 7:59 PM ET
CIK 0001044378
other material
confidence high
sentiment negative
materiality 1.00
BIOCEPT INC: going-concern / distress — Biocept files Chapter 7 bankruptcy, board and CEO resign
BIOCEPT INC
- Filed voluntary Chapter 7 petition on October 13, 2023 in Delaware Bankruptcy Court.
- A Chapter 7 trustee will liquidate assets and pay claims per the Bankruptcy Code.
- Entire board (Antonino Morales, Marsha Chandler, Bruce Gerhardt, Quyen Dao-Haddock, Ivor Royston, Linda Rubinstein) resigned effective Oct 13.
- CEO Antonino Morales also resigned as President and CEO effective Oct 13.
- Resignations not due to disagreements but due to the bankruptcy filing eliminating board powers.
Key facts
Extracted from this filing and checked against the source text.
Distress & Bankruptcy
SEC 8-K Item 1.03
confidence 0.9
BIOCEPT INC entered chapter 7 in United States Bankruptcy Court for the District of Delaware (petition 2023-10-13).
- Proceeding
- chapter 7
- Court
- United States Bankruptcy Court for the District of Delaware
- Petition
- 2023-10-13
Exact text from the filing
Biocept, Inc., a Delaware corporation (the “Company”), filed a voluntary petition for relief (the “Petition”) under the provisions of Chapter 7 of Title 11 of the United States Code, 11 U.S.C. §§ 101 et seq. (the “Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) on October 13, 2023.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Ivor Royston resigned as Director at BIOCEPT INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
Antonino Morales, Marsha A. Chandler, Bruce E. Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein (each a "Member" and collectively the "Members") tendered their resignations as members of the Company's Board of Directors which resignations were effective on October 13, 2023
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Antonino Morales resigned as President and Chief Executive Officer at BIOCEPT INC.
- Action
- resigned
- Role
- President and Chief Executive Officer
Exact text from the filing
In addition to his resignation from the Company's Board of Directors, Mr. Morales tendered his resignation as the Company's President and Chief Executive Officer effective on October 13, 2023
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Linda Rubinstein resigned as Director at BIOCEPT INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
Antonino Morales, Marsha A. Chandler, Bruce E. Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein (each a "Member" and collectively the "Members") tendered their resignations as members of the Company's Board of Directors which resignations were effective on October 13, 2023
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Quyen Dao-Haddock resigned as Director at BIOCEPT INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
Antonino Morales, Marsha A. Chandler, Bruce E. Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein (each a "Member" and collectively the "Members") tendered their resignations as members of the Company's Board of Directors which resignations were effective on October 13, 2023
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Antonino Morales resigned as Director at BIOCEPT INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
Antonino Morales, Marsha A. Chandler, Bruce E. Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein (each a "Member" and collectively the "Members") tendered their resignations as members of the Company's Board of Directors which resignations were effective on October 13, 2023
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Bruce E. Gerhardt resigned as Director at BIOCEPT INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
Antonino Morales, Marsha A. Chandler, Bruce E. Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein (each a "Member" and collectively the "Members") tendered their resignations as members of the Company's Board of Directors which resignations were effective on October 13, 2023
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Marsha A. Chandler resigned as Director at BIOCEPT INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
Antonino Morales, Marsha A. Chandler, Bruce E. Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein (each a "Member" and collectively the "Members") tendered their resignations as members of the Company's Board of Directors which resignations were effective on October 13, 2023
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.